Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith R McCrae

Showing results (41-50 of 153) with videos related to

Pageof 16
Sort By:
American Journal of Hematology|February 28, 2017
Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment toolRushad Patell, Lisa Rybicki, Keith R McCrae, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2016
Novel role for p56/Lck in regulation of endothelial cell survival and angiogenesisVenkaiah Betapudi, Meenal Shukla, Ravi Alluri, et al.
JRSM Open|July 25, 2014
Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopeniaKriti Mittal, Michael J McNamara, Brian R Curtis, et al.
Thrombosis Research|March 18, 2017
Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional surveyShruti Chaturvedi, Marianne Clancy, Nicole Schaefer, et al.
American Journal of Hematology|April 23, 2019
Bleeding incidence and risk factors among cancer patients treated with anticoagulationDana E Angelini, Tomas Radivoyevitch, Keith R McCrae, et al.
Blood|April 13, 2011
Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factorsKristi L Allen, Anne Hamik, Mukesh K Jain, et al.
Thrombosis Research|September 3, 2023
Transcriptome analysis suggests a central role for complement and C5aR1 in neutrophil activation in APSAhmed Alarabi, Anne Hubben, John Barnard, et al.
Plos One|August 16, 2014
Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancerShruti Chaturvedi, Surbhi Sidana, Paul Elson, et al.
Research and Practice in Thrombosis and Haemostasis|January 29, 2020
RNA expression and risk of venous thromboembolism in lung cancerTamara A Sussman, Mohamed E Abazeed, Keith R McCrae, et al.
Thrombosis Research|September 5, 2022
Old is new again: emergence of thromboembolic complications in cancer patients on immunotherapyKeith R McCrae, Shadi Swaidani, C Marcela Diaz-Montero, et al.
Pageof 16

Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|February 28, 2017
Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment toolRushad Patell, Lisa Rybicki, Keith R McCrae, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2016
Novel role for p56/Lck in regulation of endothelial cell survival and angiogenesisVenkaiah Betapudi, Meenal Shukla, Ravi Alluri, et al.
JRSM Open|July 25, 2014
Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopeniaKriti Mittal, Michael J McNamara, Brian R Curtis, et al.
Thrombosis Research|March 18, 2017
Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional surveyShruti Chaturvedi, Marianne Clancy, Nicole Schaefer, et al.
American Journal of Hematology|April 23, 2019
Bleeding incidence and risk factors among cancer patients treated with anticoagulationDana E Angelini, Tomas Radivoyevitch, Keith R McCrae, et al.
Blood|April 13, 2011
Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factorsKristi L Allen, Anne Hamik, Mukesh K Jain, et al.
Thrombosis Research|September 3, 2023
Transcriptome analysis suggests a central role for complement and C5aR1 in neutrophil activation in APSAhmed Alarabi, Anne Hubben, John Barnard, et al.
Plos One|August 16, 2014
Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancerShruti Chaturvedi, Surbhi Sidana, Paul Elson, et al.
Research and Practice in Thrombosis and Haemostasis|January 29, 2020
RNA expression and risk of venous thromboembolism in lung cancerTamara A Sussman, Mohamed E Abazeed, Keith R McCrae, et al.
Thrombosis Research|September 5, 2022
Old is new again: emergence of thromboembolic complications in cancer patients on immunotherapyKeith R McCrae, Shadi Swaidani, C Marcela Diaz-Montero, et al.
Pageof 16